Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.99
-0.08 (-0.40%)
At close: Mar 9, 2026, 4:00 PM EDT
20.17
+0.18 (0.90%)
After-hours: Mar 9, 2026, 5:01 PM EDT
Apellis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 22.39 | -197.88 | -528.63 | -652.17 | -746.35 | |
| Depreciation & Amortization | 1.56 | 1.8 | 1.78 | 1.55 | 1.49 | |
| Other Amortization | 2.5 | 1.56 | 0.3 | 0.46 | 0.96 | |
| Loss (Gain) From Sale of Assets | - | - | 0.12 | - | - | |
| Stock-Based Compensation | 104 | 114.13 | 105.95 | 91.09 | 70.67 | |
| Other Operating Activities | - | 10.89 | 26 | 61.09 | 203.63 | |
| Change in Accounts Receivable | -101.28 | -58.48 | -198.72 | 2.38 | -10.1 | |
| Change in Inventory | -15.27 | -10.76 | -60.65 | -69.4 | -16.32 | |
| Change in Accounts Payable | 18.22 | 1.09 | 0.17 | 18.69 | 10.49 | |
| Change in Other Net Operating Assets | 13.21 | 49.79 | 58.94 | 32.57 | -77.59 | |
| Operating Cash Flow | 45.33 | -87.87 | -594.74 | -513.75 | -563.13 | |
| Capital Expenditures | -0.31 | -0.4 | -0.77 | -1.52 | -1.1 | |
| Sale of Property, Plant & Equipment | - | - | 0.1 | - | - | |
| Investment in Securities | - | - | - | 61.42 | 248.72 | |
| Investing Cash Flow | -0.31 | -0.4 | -0.67 | 59.89 | 247.62 | |
| Long-Term Debt Issued | - | 365.45 | - | - | - | |
| Net Debt Issued (Repaid) | - | 365.45 | - | - | - | |
| Issuance of Common Stock | 8.9 | 18.83 | 461.04 | 405.84 | 398.02 | |
| Repurchase of Common Stock | -0.01 | -0.06 | -11.04 | -5.68 | -1.79 | |
| Other Financing Activities | - | -234.98 | -55.5 | -34.5 | -4 | |
| Financing Cash Flow | 8.88 | 149.24 | 394.5 | 365.66 | 392.24 | |
| Foreign Exchange Rate Adjustments | 1.25 | -0.66 | 0.14 | -0.49 | -2.02 | |
| Net Cash Flow | 55.15 | 60.31 | -200.78 | -88.68 | 74.71 | |
| Free Cash Flow | 45.01 | -88.27 | -595.51 | -515.27 | -564.23 | |
| Free Cash Flow Margin | 4.48% | -11.30% | -150.16% | -683.18% | -847.66% | |
| Free Cash Flow Per Share | 0.35 | -0.71 | -5.02 | -4.86 | -6.68 | |
| Cash Interest Paid | 41.23 | 29.37 | 3.29 | 5 | 10.27 | |
| Cash Income Tax Paid | 1.63 | 1.65 | -1.76 | 4.92 | 0.05 | |
| Levered Free Cash Flow | -15.46 | -35.7 | -404.84 | -304.6 | -351.61 | |
| Unlevered Free Cash Flow | 9.74 | -12.01 | -386.65 | -284.66 | -344.3 | |
| Change in Working Capital | -85.12 | -18.36 | -200.25 | -15.76 | -93.52 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.